Clinical Trials Directory

Trials / Completed

CompletedNCT04693312

Injection of Dorsal Scapular n at Different Levels, Dose it Make Difference?

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Dorsal scapular nerve (DSN) entrapment syndrome is an under-recognized cause of neck and shoulder pain. DSN injuries can be the origin of a well-defined chronic pain syndrome, often referred to as DSN syndrome. DSN syndrome is often characterized by a dull ache along the medial border of the scapula.

Detailed description

Dorsal scapular nerve syndrome typically presents with a weakness of the levator scapulae and the rhomboid muscles, and results in a winged scapula. A winged scapula is where the scapula protrudes from the patient's back and can affect the ability to lift objects or pull and push. The winging of the scapula seen with dorsal scapular nerve syndrome is not as severe as seen as injury or paralysis of the serratus anterior muscle. Dorsal scapular nerve entrapment is a very under-recognized cause of neck and shoulder pain. The scapular winging may be subtle, and the symptoms are easily mistaken for other problems. A careful history and physical exam, along with a high index of suspicion, are necessary for accurate diagnosis and therefore appropriate treatment. Injection of the dorsal scapular nerve under ultrasound guidance can be diagnostic as well as therapeutic.

Conditions

Interventions

TypeNameDescription
DRUGDepo medrollocal injection

Timeline

Start date
2020-01-01
Primary completion
2020-03-01
Completion
2020-07-01
First posted
2021-01-05
Last updated
2021-01-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04693312. Inclusion in this directory is not an endorsement.